Navigation Links
CELLING Treatment Centers New Clinic Revolutionizes Spinal Care with Adult Stem Cells

Now open in Austin, Texas, CELLING patients can seek out cutting-edge stem cell treatments designed to enhance their quality of life.

Austin, TX (Vocus) July 7, 2010 -- The future of medicine has arrived in Texas -- CELLING Treatment Center is newly open in Austin, providing stem cell therapies for common back and spine disorders. Minimally invasive but maximally effective, Celling Treatment Center techniques promise to set the new standard for spinal and orthopedic surgery.

Dr. Mark A. Flood, chief surgeon and medical director of the center, said, “Stem cell science has now advanced to the point where clinical applications in orthopedic and spinal surgery are now a reality.”

CELLING Treatment Centers is poised to become patient’s first choice for non-fusion strategies to treat spinal disorders and the orthopedic applications of stem cells in conditions of aging and injury. Patients can access a wide array of top quality conventional and novel treatments for back problems, joint problems, sports injuries and more. And while conventional fusion approaches can often result in painful failure, minimally invasive approaches are much more promising for both fixing the back and for avoiding post-surgical complications.

Dr. Flood is a pioneer in the use of stem cells in concert with minimally invasive approaches to orthopedic surgery on the spine and extremities. Board certified, Dr. Flood brings an extensive background in minimally invasive spine surgery methods, such as endoscopic and laser spine surgery. He is fellowship trained in both adult and pediatric spinal surgery.

Stem cells differ from ordinary cells in some significant ways. They have the unique abilities to self-renew and to divide for a long period. Under certain conditions, stem cells can be induced to differentiate into specialized cells with distinct functions including, but not limited to, cardiac cells, liver cells, fat cells, bone cells, cartilage cells, nerve cells, and connective tissue cells. As medical science develops a more precise understanding of the pure potential locked inside stem cells, clinicians like Dr. Flood can create exiting new more effective, treatments for disease, degeneration or injury.

“Dr. Mark Flood has exhibited a career long interest in adopting innovative therapies in pursuit of the best possible outcomes for his patients. He has extensive experience in minimally invasive surgical procedures and a long term interest in stem cells and cell based therapies which make him an ideal physician to partner with for the advancement of cell based therapies.” said Kevin Dunworth, Founder & CEO of Celling Technologies.

The group behind CELLING Treatment Centers sees the great potential for stem cell based treatments. They have ambitious plans to open the first surgical center and lab in the United States dedicated to the clinical application of non-embryonic stem cells across multiple medical specialties. A second site in the United States has been selected. Additional sites in Europe and the UAE are being evaluated.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patients with treatment-resistant CLL respond positively to stem cell transplants
2. Study Seeks Effective Treatment for Adolescent Low Back Pain
3. Experimental nonsteroidal treatment of asthma shows promise
4. Allegheny Medical's SportsCare Programs Combine Lifestyle, Fitness and Behavior Management with Quality Medical Treatments
5. University at Buffalo launches clinical trial of new multiple sclerosis treatment
6. New non-surgical treatment for uterine fibroids can improve quality of life
7. Alternative Menopause Treatments, Discussed by Dr. Ershadi
8. Surprising find may yield new avenue of treatment for painful herniated discs
9. Clinical Trial Testing New Multiple Sclerosis Treatment to Launch in Buffalo
10. Bursting bubbles with sound offers new treatments for cancer
11. Allergy Treatments and Symptoms Website Ready to Help
Post Your Comments:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: